RAMSY: ratio analysis of mass spectrometry to improve compound identification.

The complexity of biological samples poses a major challenge for reliable compound identification in mass spectrometry (MS). The presence of interfering compounds that cause additional peaks in the spectrum can make interpretation and assignment difficult. To overcome this issue, new approaches are needed to reduce complexity and simplify spectral interpretation. Recently, focused on unknown metabolite identification, we presented a new approach, RANSY (ratio analysis of nuclear magnetic resonance spectroscopy; Anal. Chem. 2011, 83, 7616-7623), which extracts the (1)H signals related to the same metabolite based on peak intensity ratios. On the basis of this concept, we present the ratio analysis of mass spectrometry (RAMSY) method, which facilitates improved compound identification in complex MS spectra. RAMSY works on the principle that, under a given set of experimental conditions, the abundance/intensity ratios between the mass fragments from the same metabolite are relatively constant. Therefore, the quotients of average peak ratios and their standard deviations, generated using a small set of MS spectra from the same ion chromatogram, efficiently allow the statistical recovery of the metabolite peaks and facilitate reliable identification. RAMSY was applied to both gas chromatography/MS and liquid chromatography tandem MS (LC-MS/MS) data to demonstrate its utility. The performance of RAMSY is typically better than the results from correlation methods. RAMSY promises to improve unknown metabolite identification for MS users in metabolomics or other fields.

[1]  Justin J J van der Hooft,et al.  Metabolite identification using automated comparison of high-resolution multistage mass spectral trees. , 2012, Analytical chemistry.

[2]  R. L. Brown,et al.  Development of a database of gas chromatographic retention properties of organic compounds. , 2007, Journal of chromatography. A.

[3]  V. Navratil,et al.  Orthogonal filtered recoupled-STOCSY to extract metabolic networks associated with minor perturbations from NMR spectroscopy. , 2011, Journal of proteome research.

[4]  D. Raftery,et al.  Metabolomics-based methods for early disease diagnostics , 2008, Expert review of molecular diagnostics.

[5]  Bhagwat Prasad,et al.  Metabolite identification by liquid chromatography-mass spectrometry , 2011 .

[6]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[7]  Ralf Tautenhahn,et al.  An accelerated workflow for untargeted metabolomics using the METLIN database , 2012, Nature Biotechnology.

[8]  Brett R. Wenner,et al.  Metabolomics Applied to Diabetes Research , 2009, Diabetes.

[9]  Ara W. Darzi,et al.  Metabolic phenotyping in clinical and surgical environments , 2012, Nature.

[10]  Joshua D Rabinowitz,et al.  Metabolomics in systems microbiology. , 2011, Current opinion in biotechnology.

[11]  A. Kaufmann,et al.  Correlation of precursor and product ions in single-stage high resolution mass spectrometry. A tool for detecting diagnostic ions and improving the precursor elemental composition elucidation. , 2013, Analytica chimica acta.

[12]  D. Gauguier,et al.  Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. , 2005, Analytical chemistry.

[13]  Andrew N Lane,et al.  NMR-based stable isotope resolved metabolomics in systems biochemistry , 2011, Journal of biomolecular NMR.

[14]  John C. Lindon,et al.  Metabonomics Techniques and Applications to Pharmaceutical Research & Development , 2006, Pharmaceutical Research.

[15]  O. Fiehn,et al.  FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. , 2009, Analytical chemistry.

[16]  Daniel Raftery,et al.  Ratio analysis nuclear magnetic resonance spectroscopy for selective metabolite identification in complex samples. , 2011, Analytical chemistry.

[17]  Oliver Fiehn,et al.  Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research , 2009, Metabolomics.

[18]  Laurent Rivier,et al.  Criteria for the identification of compounds by liquid chromatography–mass spectrometry and liquid chromatography–multiple mass spectrometry in forensic toxicology and doping analysis , 2003 .

[19]  R. Abagyan,et al.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.

[20]  E Holmes,et al.  Probing latent biomarker signatures and in vivo pathway activity in experimental disease states via statistical total correlation spectroscopy (STOCSY) of biofluids: application to HgCl2 toxicity. , 2006, Journal of proteome research.

[21]  B. Hammock,et al.  Mass spectrometry-based metabolomics. , 2007, Mass spectrometry reviews.

[22]  Yan Liang,et al.  Recent development in liquid chromatography/mass spectrometry and emerging technologies for metabolite identification. , 2011, Current drug metabolism.

[23]  D. Raftery,et al.  Metabolic profiling: are we en route to better diagnostic tests for cancer? , 2012, Future oncology.

[24]  S. Stein,et al.  Estimating probabilities of correct identification from results of mass spectral library searches , 1994, Journal of the American Society for Mass Spectrometry.

[25]  Xi-jun Wang,et al.  Modern analytical techniques in metabolomics analysis. , 2012, The Analyst.

[26]  Daniel Raftery,et al.  Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics , 2007, Analytical and bioanalytical chemistry.

[27]  David I. Ellis,et al.  Metabolomics: Current analytical platforms and methodologies , 2005 .

[28]  O. Fiehn.  Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.